阜博集團(03738.HK)因可換股債券獲轉換增發1.53億股
格隆匯12月31日丨阜博集團(03738.HK)宣佈,公司接獲債券持有人發出的轉換通知,涉及行使本金總額為1億港元的可換股債券所附全部轉換權。
基於換股價每股換股股份0.645港元(就係列一可換股債券而言)及每股換股股份0.70港元(就係列二可換股債券而言),合共152,602,432股換股股份已於2021年12月31日發行予債券持有人。
緊隨配發及發行換股股份後,公司已發行股份數目增至2,117,596,656股,而換股股份相當於緊接配發及發行換股股份前公司已發行股本約7.77%以及經配發及發行換股股份擴大後公司已發行股本約7.21%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.